Cantor Fitzgerald Reiterates Overweight on Enovix, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Derek Soderberg has reiterated an Overweight rating on Enovix (NASDAQ:ENVX) and maintained a $30 price target.
October 30, 2024 | 5:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Derek Soderberg has reiterated an Overweight rating on Enovix and maintained a $30 price target, indicating confidence in the company's potential for growth.
The reiteration of an Overweight rating and a $30 price target by a reputable analyst suggests a positive outlook for Enovix, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100